1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsVirginia Catalyst Grant Funding Program is sponsored by Virginia Biosciences Health Research Corporation (Virginia Catalyst). This opportunity supports mission-aligned projects and measurable outcomes.
Get alerted about grants like this
Get emailed when new opportunities from “Virginia Biosciences Health Research Corporation (Virginia Catalyst)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
strength through collaboration Our Strategic Initiatives - Actions and Results for Virginia At the Virginia Catalyst we specialize in developing and leading strategic initiatives in areas were Virginia can be a national and global leader.
We support these initiatives with grant funding for collaborative projects, investments creating research tools, and infrastructure that provide our research universities, healthcare systems and companies a competitive advantage over other regions in the country. Our goal is to have the Commonwealth of Virginia be the very best in the nation at translational medicine and commercialization.
We will achieve this by teaming up the biosciences industry with our world-class academic researchers and focusing efforts on solving large unmet medical needs.
Continuing powerful impact through our Grant Funding Program Funding through our Grant Funding Program is designed to facilitate the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. Virginia Catalyst awards these funds to help accelerate translational research and the commercialization of Virginia’s innovations.
The awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities. Learn more about our Grant Funding Program Special Webinar - How to Score High and Get Funding Previously the Virginia Catalyst and Virginia Bio co-hosted a special webinar that featured a panel of experts sharing what it takes to score highly and get funding.
Mike Grisham , President and CEO, Virginia Catalyst, Founder and CEO, GPB Scientific, Inc. Mickey Kim , former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute J ames Powers , Chairman and CEO, HemoShear Theapeutics, LLC Thomas D.
Roberts III , General Partner, Harbert Growth Partners, Harbert Management Corporation Read the full press release here Download the presentation slides We are a not-for-profit 501(c)(3) corporation created by the Virginia General Assembly and funded by the Commonwealth’s General Fund and five Virginia public research universities: George Mason University, Old Dominion University (with Eastern Virginia Medical School) , University of Virginia, Virginia Commonwealth University, and Virginia Tech.
Our mission is to advance economic development by creating competitive critical mass for Virginia life sciences through collaborations with our research universities and industry, to attract research and commercialization capital to Virginia and to catalyze the commercialization of Virginia’s innovations that meet large, unmet medical needs, improve human health and to create many more high-paying life science jobs in Virginia.
According to the current listing, eligibility includes: Collaborative efforts between industry and Virginia research universities; supports translational research and commercialization in life sciences. Confirm the full requirements in the official notice before applying.
The current listing shows $200,000 - $800,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Virginia Catalyst Grant Funding Program is funded by Virginia Biosciences Health Research Corporation (Virginia Catalyst). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Virginia. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
CMS awarded all 50 states their first-year slice of the $50 billion Rural Health Transformation Program in December 2025 — from $147M in New Jersey to $281M in Texas. Now the money is moving downstream: New Jersey and New York have already launched subaward RFAs, and rural hospitals, clinics, community organizations, and tribal groups are the eligible applicants. Here is how the allocation formula worked, what the money can and cannot fund, and the strategy to win a state subaward.
Read articleThe FY2026 Rural Health Network Advancement Program (HRSA-26-082) offers six awards of roughly $500,000 to help independent rural hospitals and clinics form integrated networks without surrendering local ownership. With a July 24, 2026 deadline and a pilot design that rewards genuine collaboration over merger, here is who qualifies, what a fundable network looks like, and how small rural providers should approach it.
Read articleThe Elevance Health Foundation's FY2026 Maternal/Infant Health cycle offers grants around $1 million (1–3 years, 15% indirects) to reduce pre-term birth and severe maternal morbidity. But eligibility hinges on a specific 501(c)(3) subsection test, funding concentrates in 10 states plus national scalable programs, and a corporate payer-funder judges you on measurable outcomes, not need. Here is how to read this RFP and compete before the July 31 deadline.
Read article